Maurice Hebert
Known title: Chief Accounting OfficerCIK: 0001267043
Associated companies
Transaction History
| MOH | ▼ Sell | Open Market | 600 | $115K | 5/14/2026 | View on chart |
| MOH | ▲ Buy | Grant | 650 | $100K | 3/1/2026 | View on chart |
| MOH | ▼ Sell | Tax Withholding | 229 | $35K | 3/1/2026 | View on chart |
| MOH | ▼ Sell | Tax Withholding | 272 | $42K | 3/1/2026 | View on chart |
| MOH | ▲ Buy | Grant | 2,058 | $300K | 3/1/2026 | View on chart |
| MOH | ▼ Sell | Tax Withholding | 656 | $198K | 3/1/2025 | View on chart |
| MOH | ▼ Sell | Tax Withholding | 303 | $91K | 3/1/2025 | View on chart |
| MOH | ▲ Buy | Grant | 1,792 | $540K | 3/1/2025 | View on chart |
| MOH | ▲ Buy | Grant | 902 | $260K | 3/1/2025 | View on chart |
| MOH | ▼ Sell | Open Market | 393 | $136K | 8/15/2024 | View on chart |
| MOH | ▼ Sell | Tax Withholding | 450 | $174K | 3/1/2024 | View on chart |
| MOH | ▼ Sell | Tax Withholding | 516 | $200K | 3/1/2024 | View on chart |
| MOH | ▲ Buy | Grant | 1,530 | $592K | 3/1/2024 | View on chart |
| MOH | ▲ Buy | Grant | 258 | $100K | 3/1/2024 | View on chart |
| MOH | ▲ Buy | Grant | 516 | $200K | 3/1/2024 | View on chart |
| MOH | ▼ Sell | Open Market | 692 | $227K | 9/13/2023 | View on chart |
| MOH | ▼ Sell | Tax Withholding | 847 | $232K | 3/1/2023 | View on chart |
| MOH | ▼ Sell | Tax Withholding | 535 | $146K | 3/1/2023 | View on chart |
| MOH | ▲ Buy | Grant | 2,652 | $726K | 3/1/2023 | View on chart |
| MOH | ▲ Buy | Grant | 730 | $200K | 3/1/2023 | View on chart |
| MOH | ▼ Sell | Tax Withholding | 113 | $37K | 10/1/2022 | View on chart |
| MOH | ▼ Sell | Tax Withholding | 267 | $83K | 3/1/2022 | View on chart |
| MOH | ▼ Sell | Tax Withholding | 800 | $250K | 3/1/2022 | View on chart |
| MOH | ▲ Buy | Grant | 1,202 | $375K | 3/1/2022 | View on chart |
| MOH | ▲ Buy | Grant | 2,168 | $676K | 3/1/2022 | View on chart |
| MOH | ▼ Sell | Tax Withholding | 102 | $28K | 10/1/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 5, 2026
Molina Healthcare Draws Value Investor Interest Amid Recent Pressure
Diamond Hill Capital has highlighted long-term value in Molina Healthcare following recent stock price pressure. This view is echoed by other market analyses questioning if the stock is a value play. The company is currently trading near its 52-week low, with an average analyst target of $209.12.
Molina Healthcare Draws Value Investor Interest Amid Recent Pressure. Diamond Hill Capital has highlighted long-term value in Molina Healthcare following recent stock price pressure. This view is echoed by other market analyses questioning if the stock is a value play. The company is currently trading near its 52-week low, with an average analyst target of $209.12.